Analysts Set Masimo Corporation (NASDAQ:MASI) PT at $181.17

Masimo Corporation (NASDAQ:MASI) has been assigned a consensus recommendation of “Reduce” from the nine brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and eight have given a hold recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $181.1667.

Several research firms have recently weighed in on MASI. Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research report on Tuesday, February 17th. Wolfe Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a report on Wednesday, March 18th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Masimo by 3.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock worth $709,717,000 after purchasing an additional 171,876 shares during the period. Massachusetts Financial Services Co. MA grew its position in Masimo by 1.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after buying an additional 43,915 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in Masimo by 9.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after buying an additional 203,395 shares during the last quarter. Naya Capital Management UK Ltd. purchased a new stake in Masimo during the fourth quarter valued at approximately $202,984,000. Finally, Westfield Capital Management Co. LP raised its position in Masimo by 7.2% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock worth $197,958,000 after acquiring an additional 102,799 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Price Performance

Shares of NASDAQ:MASI opened at $177.11 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The firm has a market cap of $9.51 billion, a price-to-earnings ratio of -16.80, a price-to-earnings-growth ratio of 1.79 and a beta of 1.21. The business has a 50-day simple moving average of $159.93 and a two-hundred day simple moving average of $148.34. Masimo has a fifty-two week low of $125.94 and a fifty-two week high of $179.00.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.